| pubmed-article:1441728 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1441728 | lifeskim:mentions | umls-concept:C0019159 | lld:lifeskim |
| pubmed-article:1441728 | lifeskim:mentions | umls-concept:C0023828 | lld:lifeskim |
| pubmed-article:1441728 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:1441728 | lifeskim:mentions | umls-concept:C0042210 | lld:lifeskim |
| pubmed-article:1441728 | lifeskim:mentions | umls-concept:C0042196 | lld:lifeskim |
| pubmed-article:1441728 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:1441728 | lifeskim:mentions | umls-concept:C0439230 | lld:lifeskim |
| pubmed-article:1441728 | lifeskim:mentions | umls-concept:C0205171 | lld:lifeskim |
| pubmed-article:1441728 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:1441728 | pubmed:dateCreated | 1992-12-1 | lld:pubmed |
| pubmed-article:1441728 | pubmed:abstractText | In the near future an inactivated hepatitis A vaccine will be commercially available. The recommended vaccination schedule will include at least two vaccinations 1 month apart. Giving two doses of vaccine on the same day in one injection results in protection after 2-4 weeks dependent on the adjuvant used. Hepatitis A virus incorporated into liposomes proved to be a suitable formulation in term of rapid seroconversion, high level of mean antibody content and low reactogenicity. | lld:pubmed |
| pubmed-article:1441728 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1441728 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1441728 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1441728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1441728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1441728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1441728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1441728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1441728 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1441728 | pubmed:issn | 0264-410X | lld:pubmed |
| pubmed-article:1441728 | pubmed:author | pubmed-author:BergerRR | lld:pubmed |
| pubmed-article:1441728 | pubmed:author | pubmed-author:JustMM | lld:pubmed |
| pubmed-article:1441728 | pubmed:author | pubmed-author:GlückRR | lld:pubmed |
| pubmed-article:1441728 | pubmed:author | pubmed-author:BrantschenSS | lld:pubmed |
| pubmed-article:1441728 | pubmed:author | pubmed-author:DreschslerHH | lld:pubmed |
| pubmed-article:1441728 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1441728 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:1441728 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1441728 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1441728 | pubmed:pagination | 737-9 | lld:pubmed |
| pubmed-article:1441728 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:meshHeading | pubmed-meshheading:1441728-... | lld:pubmed |
| pubmed-article:1441728 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1441728 | pubmed:articleTitle | A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks. | lld:pubmed |
| pubmed-article:1441728 | pubmed:affiliation | University Children's Hospital, Basel, Switzerland. | lld:pubmed |
| pubmed-article:1441728 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1441728 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1441728 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
